You've hit one of our legacy pages, and this content may be out of date. Visit our Market Landscapes page to see the latest content.
You will be redirected to the Landscapes page in 10 seconds.
MERS-CoV, the virus that causes Middle East Respiratory Syndrome (MERS), is a potent respiratory pathogen. Effective animal models are essential to facilitate the development of vaccines and treatments. With a wealth of knowledge and state-of-the-art resources, Creative Diagnostics is dedicated to providing reliable animal models of MERS-CoV infection to help customers around the world delve deeper into this complex virus. These models simulate human MERS-CoV infection by addressing key conditions, such as reproducibility, mortality associated with severe respiratory disease, absence of neurological complications from high viral loads, and sustained high viral replication in lungs.
Creative Diagnostics provides MERS-CoV Virus Tracheal Intubation Infection Rhesus Monkey Model and MERS-CoV Virus Intranasal Infection Mouse Model, offering valuable insights into disease mechanisms. In addition, Creative Diagnostics offers a comprehensive range of services to support MERS-CoV animal model studies, including study design and execution, pathological analysis and immune response profiling, efficacy testing of vaccines and antiviral compounds, and data analysis and interpretation.
Location
New York Shirley, New York 11967
Number of Employees
1-10